Stereotaxis, Inc. Common Stock (STXS) is a publicly traded Healthcare sector company. As of September 16, 2026, STXS trades at $1.33 with a market cap of $133.27M and a P/E ratio of -5.26. STXS moved +0.76% today. Year to date, STXS is -42.61%; over the trailing twelve months it is -53.19%. Its 52-week range spans $1.24 to $3.59. Analyst consensus is strong buy with an average price target of $3.00. Rallies surfaces STXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for STXS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.33 |
| Market Cap | $133.27M |
| P/E Ratio | -5.26 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.59 |
| 52-Week Low | $1.24 |
| Volume | 57.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.38M |
| Net Income | $-21.64M |
| Gross Margin | 52.73% |
3 analysts cover STXS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.00.